Intestinal lymphangiectasia: a protein-losing enteropathy with hypogammaglobulinemia, lymphocytopenia and impaired homograft rejection.

PubWeight™: 1.88‹?› | Rank: Top 3%

🔗 View Article (PMC 292913)

Published in J Clin Invest on October 01, 1967

Authors

W Strober, R D Wochner, P P Carbone, T A Waldmann

Articles citing this

Primary intestinal lymphangiectasia (Waldmann's disease). Orphanet J Rare Dis (2008) 2.15

Peripheral blood and intestinal lymphocyte sub-populations in Crohn's disease. Gut (1975) 1.77

Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry (1978) 1.68

The immune competence of patients with inflammatory bowel disease. Gut (1974) 1.43

Familial hypercatabolic hypoproteinemia. A disorder of endogenous catabolism of albumin and immunoglobulin. J Clin Invest (1990) 1.35

Hypogammaglobulinemia associated with accelerated catabolism of IgG secondary to its inteaction with an IgG-reactive monoclonal IgM. J Clin Invest (1971) 1.29

Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in man. J Clin Invest (1972) 1.22

Hypercatabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome. A unique disorder of serum protein metabolism. J Clin Invest (1971) 1.05

Intestinal lymphangiectasia in adults. World J Gastrointest Oncol (2011) 1.03

Intestinal lymphangiectasia. Long-term results with MCT diet. Arch Dis Child (1975) 1.01

Partial purine nucleoside phosphorylase deficiency. Studies of lymphocyte function. J Clin Invest (1978) 0.97

Primary intestinal lymphangiectasia: Minireview. World J Clin Cases (2014) 0.95

Malignant lymphoma and extensive viral wart formation in a patient with intestinal lymphangiectasia and lymphocyte depletion. Postgrad Med J (1977) 0.92

Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement. PLoS One (2014) 0.91

Immunoflobulins and malabsorption. Proc R Soc Med (1969) 0.87

Histopathological and electron microscopic studies of lymphangiectasia of the small intestine in Behçet's disease. Gut (1973) 0.87

The metabolism of IgE in patients with immunodeficiency states and neoplastic conditions. J Clin Invest (1977) 0.84

Immunoglobulins in myasthenia gravis. Kinetic properties of the acetylcholine-receptor antibody studied during lymph drainage. Clin Exp Immunol (1978) 0.82

Immunoglobulins and the gut. Gut (1972) 0.81

Intestinal lymphangiectasia associated with angiofollicular lymph node hyperplasia (Castleman's disease). Gut (1992) 0.81

Pediatric lymphangiectasia: an imaging spectrum. Pediatr Radiol (2014) 0.80

Intestinal lymphangiectasia and thymic hypoplasia. Clin Exp Immunol (1985) 0.80

Pleurectomy for chylothorax associated with intestinal lymphangiectasia. Thorax (1987) 0.78

Development of impaired splenic function in intestinal lymphangiectasia. Gut (1985) 0.78

Castleman's disease associated with a cerebellar chordoid meningioma and intestinal lymphangiectasia. Childs Nerv Syst (2010) 0.78

Twin infant with lymphatic dysplasia diagnosed with Noonan syndrome by molecular genetic testing. Fetal Pediatr Pathol (2014) 0.76

Hypogammaglobulinemia with facial edema. PLoS Med (2006) 0.75

A case of primary intestinal lymphangiectasia. Korean J Intern Med (1993) 0.75

Impaired neutrophil function in intestinal lymphangiectasia. J Clin Pathol (1986) 0.75

Articles cited by this

Efficient trace-labelling of proteins with iodine. Nature (1958) 23.16

QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES. J Immunol (1965) 16.97

Tracer experiments with I131 labeled human serum albumin: distribution and degradation studies. J Clin Invest (1953) 8.08

The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type. J Exp Med (1961) 6.05

Quantitative studies on tissue transplantation immunity. II. The origin, strength and duration of actively and adoptively acquired immunity. Proc R Soc Lond B Biol Sci (1954) 5.72

Estimation of Vi antibody employing erythrocytes treated with purified Vi antigen. Proc Soc Exp Biol Med (1953) 5.33

Studies on the immunological response to foreign tumor transplants in the mouse. I. The role of lymph node cells in conferring immunity by adoptive transfer. J Exp Med (1955) 4.89

Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. Gastroenterology (1960) 4.60

Chromatography of serum proteins in normal and pathologic sera: the distribution of protein-bound carbohydrate and cholesterol, siderophilin, thyroxin-binding protein, B12-binding protein, alkaline and acid phosphatases, radio-iodinated albumin and myeloma proteins. J Clin Invest (1958) 3.77

The growth of cells in vivo in diffusion chambers. II. The role of cells in the destruction of homografts in mice. J Natl Cancer Inst (1955) 3.57

METABOLISM OF HUMAN GAMMA MACROGLOBULINS. J Clin Invest (1964) 3.38

Protein-losing enteropathy. Gastroenterology (1966) 3.21

Studies on the immunological response to foreign tumor transplants in the mouse. II. The relation between hemagglutinating antibody and graft resistance in the normal mouse and mice pretreated with tissue preparations. J Exp Med (1955) 3.09

Exudative enteropathy: abnormal permeability of the gastrointestinal tract demonstrable with labelled polyvinylpyrrolidone. Lancet (1959) 2.98

Studies on Vi antigen. II. Purification of Vi antigen from Escherichia coli 5395/38. J Immunol (1952) 2.93

Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism. J Clin Invest (1966) 2.91

Gastrointestinal protein loss demonstrated by Cr-51-labelled albumin. Lancet (1961) 2.78

Passive transfer of transplantation immunity. I. Tritiated lymphoid cells. II. Lymphoid cells in millipore chambers. J Exp Med (1962) 2.60

SELECTIVITY OF PROTEIN EXCRETION IN PATIENTS WITH THE NEPHROTIC SYNDROME. J Clin Invest (1964) 2.56

Immunological deficiency diseases. Agammaglobulinemia, hypogammaglobulinemia, Hodgkin's disease and sarcoidosis. Prog Allergy (1962) 2.55

[HEREDITARY THYMIC HYPOPLASIA: ITS PLACE AND RESPONSIBILITY IN A CASE OF LYMPHOCYTIC, NORMOPLASMOCYTIC AND NORMOGLOBULINEMIC APLASIA IN AN INFANT]. Arch Fr Pediatr (1964) 2.48

Adult Thymectomy: Effect on Recovery from Immunologic Depression in Mice. Science (1965) 2.41

An investigation of Hodgkin's disease with respect to the problem of homotransplantation. Ann N Y Acad Sci (1960) 1.99

Protein-losing gastroenteropathy in congestive heart-failure. Lancet (1961) 1.92

A practical method for plasma albumin turnover studies. Strahlentherapie (1958) 1.89

IGG (7 S GAMMA GLOBULIN) METABOLISM IN HYPOGAMMAGLOBULINEMIA: STUDIES IN PATIENTS WITH DEFECTIVE GAMMA GLOBULIN SYNTHESIS, GASTROINTESTINAL PROTEIN LOSS, OR BOTH. J Clin Invest (1965) 1.80

SURVIVAL OF HOMOGRAFTS OF SKIN IN RATS DEPLETED OF LYMPHOCYTES BY CHRONIC DRAINAGE FROM THE THORACIC DUCT. Lancet (1964) 1.70

FURTHER STUDIES ON ADOPTIVE TRANSFER OF SENSITIVITY TO SKIN HOMOGRAFTS. J Exp Med (1963) 1.63

Further attempts to transfer transplantation immunity by means of serum. Br J Exp Pathol (1956) 1.55

[Agammaglobulinemia & alymphocytosis with atrophy of lymphatic tissue]. Helv Paediatr Acta (1958) 1.49

Studies on Vi antigen. IV. Physicochemical characterization of Vi antigens isolated from V form Enterobacteriaceae. J Immunol (1954) 1.45

LOW-FAT DIET IN INTESTINAL LYMPHANGIECTASIA. ITS EFFECT ON ALBUMIN METABOLISM. N Engl J Med (1964) 1.38

Serum globulin deficiencies in non-tropical sprue, with report of two cases of acquired agammaglobulinemia. Am J Med (1961) 1.33

Studies on tularemia. V. Immunization of man. J Immunol (1950) 1.31

INTESTINAL LYMPHANGIECTASIA MECHANISM OF ENTERIC LOSS OF PLASMA-PROTEIN AND FAT. Lancet (1965) 1.31

DIETARY TREATMENT OF PROTEIN LOSS IN INTESTINAL LYMPHANGIECTASIA. THE EFFECT OF ELIMINATING DIETARY LONG CHAIN TRIGLYCERIDES ON ALBUMIN METABOLISM IN THIS CONDITION. Pediatrics (1964) 1.29

Passive transfer of tuberculin hypersensitivity by viable lymphocytes from the thoracic duct. Acta Tuberc Scand (1952) 1.29

Alymphocytosis, agammaglobulinaemia, homografts, and delayed hypersen sitivity: study of a case. Lancet (1962) 1.26

Protein-losing enteropathy in constrictive pericarditis. Acta Med Scand (1963) 1.26

Measurement of gastrointestinal protein loss using ceruloplasmin labeled with copper. J Clin Invest (1967) 1.19

Antibody formation in Hodgkin's disease. N Engl J Med (1963) 1.14

Albumin metabolism in patients with Whipple's disease. J Clin Invest (1966) 1.00

Chylous effusions into the intestine in a patient with protein-losing gastroenteropathy. Pediatrics (1963) 0.95

The role of lymphoid cells in homograft rejection: circulating and cellular aspects. Transplantation (1966) 0.83

Articles by these authors

Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81

Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res (1971) 13.16

A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol (1981) 10.92

A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature (1982) 9.42

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med (2001) 8.69

Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet (1974) 8.13

Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature (1984) 7.37

Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89

Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med (1985) 6.46

Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol (1996) 6.21

Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98

Metabolism of immunoglobulins. Prog Allergy (1969) 5.74

Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest (1998) 5.70

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell (1995) 5.64

Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens. Nature (2011) 5.41

Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med (1970) 5.03

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland. Cancer (1977) 4.95

Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A (1984) 4.90

Clustered arrangement of immunoglobulin lambda constant region genes in man. Nature (1981) 4.87

Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc Natl Acad Sci U S A (1986) 4.61

The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci U S A (1989) 4.22

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med (1996) 4.09

Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells. N Engl J Med (1975) 3.81

Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci U S A (1985) 3.74

Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc Natl Acad Sci U S A (1981) 3.73

Assessment of response to therapy in advanced breast cancer. Br J Cancer (1977) 3.70

Human immunoglobulin kappa light-chain genes are deleted or rearranged in lambda-producing B cells. Nature (1981) 3.64

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med (1992) 3.54

Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med (1998) 3.50

Metabolic properties of IgG subclasses in man. J Clin Invest (1970) 3.48

The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest (1972) 3.43

The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. Science (1986) 3.32

Expression of interleukin 2 receptors on activated human B cells. J Exp Med (1984) 3.27

Protein-losing enteropathy. Gastroenterology (1966) 3.21

T-cell regulation of murine IgA synthesis. J Exp Med (1979) 3.11

Predominance of histocompatibility antigen HL-A8 in patients with gluten-sensitive enteropathy. J Clin Invest (1972) 3.09

The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments. J Exp Med (1967) 3.06

Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med (1983) 2.96

Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol (1999) 2.92

Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. J Clin Invest (1983) 2.91

Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism. J Clin Invest (1966) 2.91

The mechanism of intestinal uptake and transcellular transport of IgG in the neonatal rat. J Clin Invest (1972) 2.88

IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci U S A (2000) 2.80

The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A (1994) 2.79

Characterization of the human receptor for T-cell growth factor. Proc Natl Acad Sci U S A (1983) 2.76

Variable amplification of immunoglobulin lambda light-chain genes in human populations. Nature (1983) 2.75

Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci U S A (1983) 2.73

A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J Immunol (1981) 2.73

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med (1996) 2.68

The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol (1976) 2.65

Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation. J Immunol (1983) 2.65

NIH conference. Gastrointestinal infections in AIDS. Ann Intern Med (1992) 2.62

The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet (1968) 2.61

NIH conference. New insights into common variable immunodeficiency. Ann Intern Med (1993) 2.52

A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A (1994) 2.51

Ataxia-telangiectasia. Medicine (Baltimore) (1972) 2.50

Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol (1993) 2.48

The mechanism of appearance of immunoglobulin A in nasal secretions in man. J Clin Invest (1967) 2.45

Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol (2001) 2.42

Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch. J Exp Med (1996) 2.38

Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med (1967) 2.38

Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol (1997) 2.35

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc Natl Acad Sci U S A (1998) 2.33

The Sézary syndrome: a malignant proliferation of helper T cells. J Clin Invest (1976) 2.32

Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med (1996) 2.30

Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med (1973) 2.30

Dermatitis herpetiformis: the skin and the gut. Ann Intern Med (1980) 2.24

IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity (1996) 2.23

A humanized antibody that binds to the interleukin 2 receptor. Proc Natl Acad Sci U S A (1989) 2.23

Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci U S A (1989) 2.23

The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc Natl Acad Sci U S A (1987) 2.22

Separation of human blood monocytes and lymphocytes on a continuous Percoll gradient. J Immunol Methods (1980) 2.21

Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen. J Immunol (1984) 2.20

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med (1999) 2.20

Dynamic, yet structured: The cell membrane three decades after the Singer-Nicolson model. Proc Natl Acad Sci U S A (2003) 2.20

Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. I. T cells derived from Peyer's patches that switch sIgM B cells to sIgA B cells in vitro. J Exp Med (1983) 2.19

The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J Exp Med (1996) 2.17

Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity (1995) 2.17

Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature (1998) 2.17

TNBS-colitis. Int Rev Immunol (2000) 2.17

The murine Kupffer cell. I. Characterization of the cell serving accessory function in antigen-specific T cell proliferation. J Immunol (1979) 2.15

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology (1999) 2.15

Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. Proc Natl Acad Sci U S A (1999) 2.14

Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med (1969) 2.13

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest (1992) 2.13

A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature (1989) 2.13

Only high-affinity receptors for interleukin 2 mediate internalization of ligand. Proc Natl Acad Sci U S A (1986) 2.12

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood (1997) 2.10

NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Ann Intern Med (1984) 2.10

Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med (2001) 2.10

Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med (1994) 2.07

Systemic capillary leak syndrome and monoclonal IgG gammopathy; studies in a sixth patient and a review of the literature. Medicine (Baltimore) (1977) 2.07